massachusetts institute of technology

massachusetts institute of technology

InVivo Therapeutics- Company Presentation

20h ago
SOURCE  

Description

Presented by: Tom Ulich, M.D., Chief Scientific Officer InVivo Therapeutics is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The Company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology (MIT), and Joseph Vacanti, M.D., who is affiliated with Massachusetts General Hospital. InVivo is developing biocompatible neuro-spinal scaffolds to treat acute SCI and neuro-spinal scaffolds plus stem cells to treat chronic SCI. Data on InVivo’s scaffold and scaffold plus stem cells technology was first published in the Proceedings of the National Academy of Sciences (PNAS) in 2002 and has since been demonstrated to successfully promote functional recovery following traumatic spinal cord injury in several models. Data from InVivo’s pilot non-human primate study was published in the Journal of Neuroscience Methods in 2010, which earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. For more information on the 2014 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com